Position in PLRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,948,132
+$61,845 QoQ
Shares Held
1,546,137
0.0% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BML Capital Management, LLC holds $125,623,464 across 10 Biotechnology names. PLRX ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
|
14,250,000 | $53,437,500 | |
| 2 | AVIR |
Atea Pharmaceuticals, Inc.
|
7,058,657 | $37,975,574 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
3,167,231 | $10,768,585 | |
| 4 | PMVP |
PMV Pharmaceuticals, Inc.
|
5,320,000 | $6,596,800 | |
| 5 | KZR |
Kezar Life Sciences, Inc.
|
720,787 | $5,348,239 | |
| 6 | TIL |
Instil Bio, Inc.
|
645,600 | $5,319,744 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
154,961 | $2,153,957 | |
| 8 | PLRX |
Pliant Therapeutics, Inc.
This page
|
1,546,137 | $1,948,132 |
All Filings in PLRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,948,132 | 1,546,137 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,886,287 | 1,546,137 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||